MD Biosciences is a niche preclinical research group working with biopharmacuetical and medica device companies. Our core therapeutic areas are inflammation, CNS, pain and cardiovascular with an emphasis on the interplay between these systems.
We place heavy emphasis on the scientific rationale of each study to ensure that it meets the goals of the R&D program. We are willing to invest in custom study design, development and validation with our sponsors to achieve clinically relevant data at the preclinical stages. We feel that this will help reduce the failure rate in clincial stages and the burden upon the industry.